# REPL ETFs: 26 Funds That Hold Replimune Group Inc

> 26 thematic and core ETFs hold Replimune Group Inc (REPL). DWAS holds the most, at 1.88% of the fund on Nov 17, 2026. Weights and dates for every holder.

Data as of Nov 19, 2026. Rebuilt every trading night.

## ETFs that hold Replimune Group Inc

26 thematic and core ETFs hold Replimune Group Inc , by holdings dated Jun 30, 2026 to Nov 17, 2026 . DWAS holds the most, at 1.88% of the fund on Nov 17, 2026 . The next largest are CANC (1.13%) and BBC (0.84%).

1 income and other fund on it is listed below.

### Thematic and core funds that hold it

| Fund | Name | Share of the fund | Holdings filed | Asset |
| --- | --- | --- | --- | --- |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 1.88% | Nov 17, 2026 | Equity |
| CANC | Tema Oncology ETF | 1.13% | Nov 17, 2026 | Equity |
| BBC | Virtus Biotech Clinical Trials ETF | 0.84% | Jul 31, 2026 | Equity |
| MEDX | Horizon Kinetics Medical ETF | 0.73% | Jun 30, 2026 | Equity |
| LFSC | F/m Emerald Life Sciences Innovation ETF | 0.55% | Aug 31, 2026 | Equity |
| XBI | State Street SPDR S&P Biotech ETF | 0.52% | Nov 17, 2026 | Equity |
| IWC | iShares Micro-Cap ETF | 0.42% | Nov 17, 2026 | Equity |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.12% | Nov 17, 2026 | Equity |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.12% | Nov 17, 2026 | Equity |
| IBB | iShares Biotechnology ETF | 0.12% | Nov 17, 2026 | Equity |
| IWN | iShares Russell 2000 Value ETF | 0.11% | Nov 17, 2026 | Equity |
| VTWV | Vanguard Russell 2000 Value ETF | 0.09% | Oct 31, 2026 | Equity |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.09% | Sep 30, 2026 | Equity |
| IWM | iShares Russell 2000 ETF | 0.06% | Nov 17, 2026 | Equity |
| RSSL | Global X Russell 2000 ETF | 0.06% | Nov 11, 2026 | Equity |
| PWS | Pacer WealthShield ETF | 0.06% | Jul 31, 2026 | Equity |
| VTWO | Vanguard Russell 2000 ETF | 0.05% | Oct 31, 2026 | Equity |
| GSSC | GS ActiveBeta U.S. Small Cap Equity ETF | 0.03% | Aug 31, 2026 | Equity |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.03% | Jun 30, 2026 | Equity |
| SCHA | Schwab U.S. Small-Cap ETF | 0.02% | Aug 31, 2026 | Equity |
| VXF | Vanguard Extended Market ETF | 0.02% | Oct 31, 2026 | Equity |
| VHT | Vanguard Health Care ETF | 0.01% | Oct 31, 2026 | Equity |
| VTHR | Vanguard Russell 3000 ETF | Replimune Group Inc (ticker REPL, listed in US) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund’s N-PORT asset type. A fund holding only the company’s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out.

Each row shows the date the fund last filed.

Look up another company .

### Questions people ask

Which ETFs hold Replimune Group Inc? 26 thematic and core ETFs hold Replimune Group Inc, by holdings dated Jun 30, 2026 to Nov 17, 2026. The largest positions are DWAS at 1.88% of the fund on Nov 17, 2026, CANC at 1.13% of the fund on Nov 17, 2026 and BBC at 0.84% of the fund on Jul 31, 2026. 1 income and other fund on it is listed apart.

---

Source: ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.
Cite: ETFIQ, ETFs holding Replimune Group Inc, data as of Nov 19, 2026. https://etfiq.com/holdings/repl/
Licence: https://etfiq.com/license/ Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.
HTML: https://etfiq.com/holdings/repl/
